BASI Financial Facts

Cost of service revenue: 3.37M
Total cost of revenue: 4.05M
See Full Income Statement

Revolving line of credit: 0
Long-term debt, less current portion: 4.65M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 12/22/14 EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -100.0%
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
12/22/14 Q414 N/AN/A N/A N/AN/A N/A N/A N/A
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A Details
10/18/13 Q313 $0.07$0.01 +$0.06$5.6M$5.65M N/A Details
5/15/13 Q213 -$0.02$0.01 -$0.03$5.16M$5.74M N/A Details
2/14/13 Q113 $0.02-$0.03 +$0.05$5.8M$6.65M N/A Details